These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32994594)

  • 1. Combination budesonide/formoterol inhaler as sole reliever therapy in Māori and Pacific people with mild and moderate asthma.
    Hardy J; Tewhaiti-Smith J; Baggott C; Fingleton J; Semprini A; Holliday M; Hancox RJ; Weatherall M; Harwood M
    N Z Med J; 2020 Aug; 133(1520):61-72. PubMed ID: 32994594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
    Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
    Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma.
    Pilcher J; Patel M; Smith A; Davies C; Pritchard A; Travers J; Black P; Weatherall M; Beasley R; Harwood M;
    Respirology; 2014 Aug; 19(6):842-51. PubMed ID: 24889937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
    Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG
    Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
    Patel M; Pilcher J; Pritchard A; Perrin K; Travers J; Shaw D; Holt S; Harwood M; Black P; Weatherall M; Beasley R;
    Lancet Respir Med; 2013 Mar; 1(1):32-42. PubMed ID: 24321802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
    Rabe KF; Atienza T; Magyar P; Larsson P; Jorup C; Lalloo UG
    Lancet; 2006 Aug; 368(9537):744-53. PubMed ID: 16935685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study.
    O'Byrne PM; FitzGerald JM; Bateman ED; Barnes PJ; Zheng J; Gustafson P; Lamarca R; Puu M; Keen C; Alagappan VKT; Reddel HK
    Lancet Respir Med; 2021 Feb; 9(2):149-158. PubMed ID: 33010810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial.
    Papi A; Marku B; Scichilone N; Maestrelli P; Paggiaro P; Saetta M; Nava S; Folletti I; Bertorelli G; Bertacco S; Contoli M; Plebani M; Barbaro MPF; Spanevello A; Aliani M; Pannacci M; Morelli P; Beghé B; Fabbri LM;
    Lancet Respir Med; 2015 Feb; 3(2):109-119. PubMed ID: 25481378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma.
    McCormack PL; Lyseng-Williamson KA
    Drugs; 2007; 67(16):2407-31. PubMed ID: 17983258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.
    van Schayck OC; Haughney J; Aubier M; Selroos O; Ekström T; Ostinelli J; Buhl R
    Respir Med; 2012 Feb; 106(2):189-96. PubMed ID: 22119455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.
    Takeyama K; Kondo M; Tagaya E; Kirishi S; Ishii M; Ochiai K; Isono K; Tamaoki J
    Allergy Asthma Proc; 2014; 35(2):141-7. PubMed ID: 24717791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.
    Miller E; FitzGerald JM
    Can J Clin Pharmacol; 2008; 15(2):e165-76. PubMed ID: 18515918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
    Ställberg B; Ekström T; Neij F; Olsson P; Skoogh BE; Wennergren G; Löfdahl CG;
    Respir Med; 2008 Oct; 102(10):1360-70. PubMed ID: 18723335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.
    Price DB; Thomas V; Richard Dekhuijzen PN; Bosnic-Anticevich S; Roche N; Lavorini F; Raju P; Freeman D; Nicholls C; Small IR; Sims E; Safioti G; Canvin J; Chrystyn H
    BMC Pulm Med; 2018 Jun; 18(1):107. PubMed ID: 29954359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.
    Beasley R; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Pavord ID; Williams M; Weatherall M;
    N Engl J Med; 2019 May; 380(21):2020-2030. PubMed ID: 31112386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma maintenance and reliever therapy: Should this be the standard of care?
    Cusack RP; Satia I; O'Byrne PM
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):150-155. PubMed ID: 32339657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.
    Bateman ED; Reddel HK; O'Byrne PM; Barnes PJ; Zhong N; Keen C; Jorup C; Lamarca R; Siwek-Posluszna A; FitzGerald JM
    N Engl J Med; 2018 May; 378(20):1877-1887. PubMed ID: 29768147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial.
    Pilcher J; Patel M; Pritchard A; Thayabaran D; Ebmeier S; Shaw D; Black P; Braithwaite I; Weatherall M; Beasley R
    NPJ Prim Care Respir Med; 2017 May; 27(1):33. PubMed ID: 28496190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial.
    Pavord ID; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Williams M; Weatherall M; Beasley R;
    Lancet Respir Med; 2020 Jul; 8(7):671-680. PubMed ID: 32171064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.